Haller C, Padmanabhan J, Lizano P, Torous J, Keshavan M. Recent advances in understanding schizophrenia. F1000Prime Rep. 2014;6. doi:10.12703/p6-57. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108956/pdf/medrep-06-57.pdf. Accessed 9/2016.
Speerforck S, Schomerus G, Pruess S, Angermeyer M. Different biogenetic causal explanations and attitudes towards persons with major depression, schizophrenia and alcohol dependence: Is the concept of a chemical imbalance beneficial?. Journal of Affective Disorders. 2014;168:224-228. doi:10.1016/j.jad.2014.06.013. http://www.jad-journal.com/article/S0165-0327(14)00374-7/abstract. Accessed 9/2016.
Haslam N, Kvaale E. Biogenetic Explanations of Mental Disorder: The Mixed-Blessings Model. Current Directions in Psychological Science. 2015;24(5):399-404. doi:10.1177/0963721415588082. http://cdp.sagepub.com/content/24/5/399.ab. Accessed 9/2016.
Ksir C, Hart C. Cannabis and Psychosis: a Critical Overview of the Relationship. Current Psychiatry Reports. 2016;18(2). doi:10.1007/s11920-015-0657-y.
National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: The NICE guideline on treatment and management, CG178. https://www.nice.org.uk/guidance/cg178. 2014. Accessed 9/2016.
Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, D.C.: American Psychiatric Association; 2013.
Kahn R, Sommer I. The neurobiology and treatment of first-episode schizophrenia. Molecular Psychiatry. 2014;20(1):84-97. doi:10.1038/mp.2014.66.